Login
$INVZ
$0.23 +$0.01 (3.28%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q4 FY2020
As of Dec 31, 2020
ASSETS
CURRENT ASSETS:
Cash and Cash Equivalent
Short-term restricted cash
Bank deposits
Marketable securities
Trade receivables, net
Inventory
Prepaid expenses and other current assets
Total current assets
LONG-TERM ASSETS:
Marketable securities
Restricted deposits
Property and equipment, net
Operating lease right-of-use assets, net
Other long-term assets
Total long-term assets
Total assets
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Trade payables
Deferred revenues
Employees and payroll accruals
Accrued expenses and other current liabilities
Operating lease liabilities
Total current liabilities
LONG-TERM LIABILITIES:
Deferred revenues
Operating lease liabilities
Warrants liability
Total long-term liabilities
SHAREHOLDERS' EQUITY:
Ordinary shares of no-par value: Authorized: 500,000,000 shares as of December 31, 2025 and 2024; Issued and outstanding: 214,090,980 and 169,397,030 shares as of December 31, 2025 and 2024, respectively
Additional paid-in capital
Accumulated deficit
Total shareholders' equity
Total liabilities and shareholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support